Skip to content

Tag: Long acting

Explore our medication guides and pharmacology articles within this category.

What is the New Injectable Drug for Schizophrenia? Examining Latest Approvals

2 min read
In September 2025, Amneal Pharmaceuticals received U.S. FDA approval for its Risperidone Extended-Release Injectable Suspension, marking the most recent addition to the long-acting injectable options for schizophrenia. This provides another valuable tool for clinicians and patients in managing this chronic condition, addressing the critical issue of treatment adherence.

Is Amlodipine a Long-Acting Calcium Channel Blocker?

4 min read
With a half-life ranging from 30 to 50 hours, amlodipine is unequivocally classified as a long-acting calcium channel blocker (CCB). This prolonged duration of action is a key feature that distinguishes it from shorter-acting alternatives, making it a cornerstone medication for managing hypertension and stable angina.

What is a schizophrenic shot?: A Comprehensive Guide to Long-Acting Injectable Antipsychotics

6 min read
Did you know that poor adherence to daily oral antipsychotic medication is a major factor in relapses and hospitalizations for people with schizophrenia? To address this, healthcare providers often recommend what is colloquially known as a schizophrenic shot, which are long-acting injectable (LAI) medications designed to provide a steady supply of medication over an extended period.

What is Foquest?: A Complete Guide to This Long-Acting ADHD Medication

4 min read
In Canada, Foquest was the first methylphenidate product approved with a 16-hour duration of action, offering a once-daily solution for managing ADHD symptoms. As a central nervous system stimulant, **Foquest** uses a unique multi-layer bead technology to provide sustained release of medication throughout the day.